anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Aida

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 3,551
Current window 1,081-1,110
Pages 119
Rows per page 30
Arc: Aidaclear collectionreset all
18 30 60

Arc

1,081-1,110 of 3,551

filter-aware
37
Taysha | IPO Presentation Deck | 66 slidesTaysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
38
The slide uses a consistent structure for each pipeline asset: program name, target indication, development stage, disease description, and prevalence.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
39
The background features a DNA gel electrophoresis image, reinforcing the genetic theme.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
40
The slide uses a list-based structure to detail the mechanism, clinical impact, and prevalence for each pipeline asset.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
41
The slide highlights infrastructure capabilities, specifically listing Sartorius equipment and color-coded floor plan areas.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
42
The slide includes a footnote clarifying the cash position as of June 30, 2020, adjusted for subsequent financing.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
43
The slide uses a T-shaped graphic as a visual anchor, likely referencing the company's branding or a 'T' for 'Timeline'.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
44
Taysha | IPO Presentation Deck | 66 slidesTaysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
45
The image is a classic representation of DNA sequencing or fingerprinting, often used in biotech pitch decks to signify core proprietary technology.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
46
The diagram illustrates a molecular biology workflow for AAV capsid engineering.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
47
The slide highlights the potential to bypass immune responses for gene therapy redosing.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
48
Includes a disclaimer about intellectual property rights at the bottom.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
49
The slide uses a numbered process flow (1-5) to explain a biological mechanism.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
50
The slide outlines a specific R&D process (Reg1 and MiRARE) for gene therapy target identification.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
51
The slide highlights a specific 'miRARE' target panel derived from the data analysis.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
52
The background features a gel electrophoresis image, common in biotech/genomics pitch decks.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
53
The chart is a box-and-whisker plot comparing age of onset, death, and last report across multiple genetic conditions, highlighting SURF1.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
54
Includes a molecular diagram of glycogen branching and a therapeutic component breakdown (AAV9 + hGBE1 + Intrathecal delivery).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
55
Includes a bar chart of EPM2A/EPM2B cases by country and a biological process diagram showing the transition from glycogen to Lafora bodies.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
56
Includes a scientific diagram of glycogen branching and a bar chart showing Gys1 deficiency impact.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
57
The slide uses Kaplan-Meier survival curves and longitudinal body mass measurements to validate the therapeutic hypothesis.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
58
Includes a visual representation of MAPT mutations linked to specific FTLD-tau subtypes and a process diagram of tau aggregation.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
59
The background image is a DNA gel electrophoresis, suggesting a biotech or genetic research context.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
60
Includes a visual mechanism of action diagram showing the silencing of Ube3a-ATS to restore Ube3a expression.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
61
Includes a visual representation of the genetic mechanism (Typical vs Premutation vs Full mutation).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
62
Includes a bar chart of clinical features and a schematic of the AAV9-shRNA mechanism.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
63
The background features a DNA gel electrophoresis image, reinforcing the genetic focus.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
64
Includes a biological diagram of the synapse and a therapeutic approach summary (AAV9 + hSLC6A1 + Intrathecal delivery).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
65
Includes a visual equation for the therapeutic approach (AAV9 + hSLC13A5 + Intrathecal delivery).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
66
Includes a diagram of the KCNQ2 protein structure and a visual representation of a gene therapy approach (AAV9 + hKCNQ2 + Intrathecal delivery).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit